没人告诉我，我只好搜了一下，发现大师Soros也栽了

http://www.nasdaq.com/article/george-soros-owns-205-million-worth-of-these-two-stocks-cm57865

Action to Take --> Shares of Dendreon have slumped to $35, though some analysts think they could rebound to $50 or even $60 once Dendreon's picture clarifies. I'm no biotech expert, but George Soros employs plenty of them. And his team strongly believes in Dendreon's prospects -- and that kind of vetting counts for a lot. Meanwhile, Teva clearly looks like a low-risk way to play the ongoing generic drug revolution. Between Teva and Dendreon, investors will likely do well riding Soros' coattails.

 

所以炒股不要听他人的，特别是大师的